Marc Le Borgne

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

Scientific reports

Université Claude Bernard Lyon 1 - Domaine de Rockefeller

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Claude Bernard Lyon 1 - Domaine de Rockefeller Oct 01 2008

France

Professeur des Universités :: Science du Médicament

Publications

Jean Guillon, Marc Le Borgne, Vittoria Milano, Aurore Guédin-Beaurepaire, Stéphane Moreau, Noël Pinaud, Luisa Ronga, Solène Savrimoutou, Sandra Albenque-Rubio, Mathieu Marchivie, Haouraa Kalout, Charley Walker, Louise Chevallier, Corinne Buré, Eric Largy, Valérie Gabelica, Jean-Louis Mergny, Virginie Baylot, Jacky Ferrer, Yamina Idrissi, Edith Chevret, David Cappellen, Vanessa Desplat, Zsuzsanna Schelz, István Zupkó
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Boglárka Papp, Marc Le Borgne, Florent Perret, Christelle Marminon, Liza Józsa, Ágota Pető, Dóra Kósa, Lajos Nagy, Sándor Kéki, Zoltán Ujhelyi, Ádám Pallér, István Budai, Ildikó Bácskay, Pálma Fehér
Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients. Pharmaceutics 15 (12) (2023)
Boglárka Papp, Marc Le Borgne, Florent Perret, Christelle Marminon, Liza Józsa, Ágota Pető, Dóra Kósa, Lajos Nagy, Sándor Kéki, Zoltán Ujhelyi, Ádám Pallér, István Budai, Ildikó Bácskay, Pálma Fehér
Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients. Pharmaceutics 15 (12) (2023)
Jean Guillon, Marc Le Borgne, Vittoria Milano, Aurore Guédin-Beaurepaire, Stéphane Moreau, Noël Pinaud, Luisa Ronga, Solène Savrimoutou, Sandra Albenque-Rubio, Mathieu Marchivie, Haouraa Kalout, Charley Walker, Louise Chevallier, Corinne Buré, Eric Largy, Valérie Gabelica, Jean-Louis Mergny, Virginie Baylot, Jacky Ferrer, Yamina Idrissi, Edith Chevret, David Cappellen, Vanessa Desplat, Zsuzsanna Schelz, István Zupkó
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Jean Guillon, Marc Le Borgne, Vittoria Milano, Aurore Guédin-Beaurepaire, Stéphane Moreau, Noël Pinaud, Luisa Ronga, Solène Savrimoutou, Sandra Albenque-Rubio, Mathieu Marchivie, Haouraa Kalout, Charley Walker, Louise Chevallier, Corinne Buré, Eric Largy, Valérie Gabelica, Jean-Louis Mergny, Virginie Baylot, Jacky Ferrer, Yamina Idrissi, Edith Chevret, David Cappellen, Vanessa Desplat, Zsuzsanna Schelz, István Zupkó
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Caroline Bayart, Angélique Mularoni, Nada Hemmani, Soumeya Kerachni, Joachim Jose, Patrice Gouet, Joseph Paladino, Marc Le Borgne
Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Brigitte Grosgogeat, Alina Vaicelyte, Rémy Gauthier, Christine Janssen, Marc Le Borgne
Toxicological Risks of the Cobalt-Chromium Alloys in Dentistry: A Systematic Review. Materials (Basel, Switzerland) 15 (17) (2022)
Robin Birus, Ehab El-Awaad, Laurens Ballentin, Faten Alchab, Dagmar Aichele, Laurent Ettouati, Claudia Götz, Marc Le Borgne, Joachim Jose
4,5,7-trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects. FEBS open bio (2021)
Ehab El-Awaad, Robin Birus, Christelle Marminon, Zouhair Bouaziz, Laurens Ballentin, Dagmar Aichele, Marc Le Borgne, Joachim Jose
Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Diogo Henrique Kita, Nathalie Guragossian, Ingrid Fatima Zattoni, Vivian Rotuno Moure, Fabiane Gomes de Moraes Rego, Sabrina Lusvarghi, Thomas Moulenat, Billel Belhani, Fabiane Gomes de Moraes Rego, Sofiane Bouacida, Zouhair Bouaziz, Christelle Marminon, Malika Berredjem, Joachim Jose, Marcos Brown Gonçalves, Suresh V Ambudkar, Glaucio Valdameri, Marc Le Borgne
Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles. Scientific reports 11 (1) (2021)
Dounia Sid, Milad Baitiche, Zineb Elbahri, Ferhat Djerboua, Mokhtar Boutahala, Zouhair Bouaziz, Marc Le Borgne
Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Jean Guillon, Shweta Nim, Stéphane Moreau, Luisa Ronga, Solène Savrimoutou, Elisabeth Thivet, Mathieu Marchivie, Attilio Di Pietro, Rajendra Prasad, Marc Le Borgne
Synthesis of new piperazinyl-pyrrolo[1,2- a ]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald-Hartwig cross-coupling reaction. RSC advances 10 (5) (2020)
Nicolas Lebouvier, Fabrice Pagniez, Young Min Na, Da Shi, Patricia Pinson, Mathieu Marchivie, Jean Guillon, Tarek Hakki, Rita Bernhardt, Sook Wah Yee, Claire Simons, Marie-Pierre Lézé, Rolf W Hartmann, Angélique Mularoni, Guillaume Le Baut, Isabelle Krimm, Ruben Abagyan, Patrice Le Pape, Marc Le Borgne
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Fabrice Pagniez, Nicolas Lebouvier, Young Min Na, Isabelle Ourliac-Garnier, Carine Picot, Marc Le Borgne, Patrice Le Pape
Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Alexandre Bancet, Claire Raingeval, Thierry Lomberget, Marc Le Borgne, Jean-François Guichou, Isabelle Krimm
Fragment Linking Strategies for Structure-Based Drug Design. Journal of medicinal chemistry 63 (20) (2020)
Samar Issa, Anthony Prandina, Nicolas Bedel, Pål Rongved, Saïd Yous, Marc Le Borgne, Zouhair Bouaziz
Carbazole scaffolds in cancer therapy: a review from 2012 to 2018. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Ghina Alameh, Agnès Emptoz-Bonneton, Marc Rolland de Ravel, Eva L Matera, Elisabeth Mappus, Patrick Balaguer, Luc Rocheblave, Thierry Lomberget, Charles Dumontet, Marc Le Borgne, Michel Pugeat, Catherine Grenot, Claude Y Cuilleron
In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Claire Raingeval, Olivier Cala, Béatrice Brion, Marc Le Borgne, Roderick Eliot Hubbard, Isabelle Krimm
1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Geir Kildahl-Andersen, Christian Schnaars, Anthony Prandina, Sylvie Radix, Marc Le Borgne, Lars Petter Jordheim, Tor Gjøen, Adriana Magalhães Santos Andresen, Silje Lauksund, Christopher Fröhlich, Ørjan Samuelsen, Pål Rongved, Ove Alexander Høgmoen Åstrand
Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors. MedChemComm 10 (4) (2019)
Benoît Bestgen, Isabelle Krimm, Irina Kufareva, Ahmed Ashraf Moustafa Kamal, Wei-Guang Seetoh, Chris Abell, Rolf Wolfgang Hartmann, Ruben Abagyan, Claude Cochet, Marc Le Borgne, Matthias Engel, Thierry Lomberget
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site. Journal of medicinal chemistry 62 (4) (2019)
Benoît Bestgen, Irina Kufareva, Wei-Guang Seetoh, Chris Abell, Rolf Wolfgang Hartmann, Ruben Abagyan, Marc Le Borgne, Odile Filhol-Cochet, Claude Cochet, Thierry Lomberget, Matthias Engel
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action. Journal of medicinal chemistry 62 (4) (2019)
Irina Kufareva, Benoit Bestgen, Paul Brear, Renaud Prudent, Béatrice Laudet, Virginie Moucadel, Mohamed Ettaoussi, Celine F Sautel, Isabelle Krimm, Matthias Engel, Odile Filhol-Cochet, Marc Le Borgne, Thierry Lomberget, Claude Cochet, Ruben Abagyan
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors. Scientific reports 9 (1) (2019)
Samer Haidar, Christelle Marminon, Dagmar Aichele, Abdelhamid Nacereddine, Wael Zeinyeh, Abdeslem Bouzina, Malika Berredjem, Laurent Ettouati, Zouhair Bouaziz, Marc Le Borgne, Joachim Jose
QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor. Molecules (Basel, Switzerland) 25 (1) (2019)
Mehdi Bouchouit, Sofiane Bouacida, Bachir Zouchoune, Hocine Merazig, Silvia Bua, Zouhair Bouaziz, Marc Le Borgne, Claudiu T Supuran, Abdelmalek Bouraiou
Synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Sylwia Bloch, Bożena Nejman-Faleńczyk, Karolina Pierzynowska, Ewa Piotrowska, Alicja Węgrzyn, Christelle Marminon, Zouhair Bouaziz, Pascal Nebois, Joachim Jose, Marc Le Borgne, Sarmistha Saha, Grzegorz Wegrzyn
Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Abdelhamid Nacereddine, Andre Bollacke, Eszter Róka, Christelle Marminon, Zouhair Bouaziz, Ferenc Fenyvesi, Ildikó Katalin Bácskay, Joachim Jose, Florent Perret, Marc Le Borgne
Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7. Pharmaceuticals (Basel, Switzerland) 11 (1) (2018)
Christian Schnaars, Geir Kildahl-Andersen, Anthony Prandina, Roya Popal, Sylvie Radix, Marc Le Borgne, Tor Gjøen, Adriana Magalhães Santos Andresen, Adam Heikal, Ole Andreas Økstad, Christopher Fröhlich, Ørjan Samuelsen, Silje Lauksund, Lars Petter Jordheim, Pål Rongved, Ove Alexander Høgmoen Åstrand
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors. ACS infectious diseases 4 (9) (2018)
Abdeslem Bouzina, Khaoula Bechlem, Hajira Berredjem, Billel Belhani, Imène Becheker, Jacques Lebreton, Marc Le Borgne, Zouhair Bouaziz, Christelle Marminon, Malika Berredjem
Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates. Molecules (Basel, Switzerland) 23 (7) (2018)
Anthony Prandina, Lars Herfindal, Sylvie Radix, Pål Rongved, Stein Ove Døskeland, Marc Le Borgne, Florent Perret
Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Jennifer Hochscherf, Dirk Lindenblatt, Benedict Witulski, Robin Birus, Dagmar Aichele, Christelle Marminon, Zouhair Bouaziz, Marc Le Borgne, Joachim Jose, Karsten Niefind
Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'. Pharmaceuticals (Basel, Switzerland) 10 (4) (2017)

Marc Le Borgne.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Le Borgne